Cite
HARVARD Citation
Chibaudel, B. et al. (n.d.). Induction therapy with cetuximab plus docetaxel, cisplatin, and 5‐fluorouracil (ETPF) in patients with resectable nonmetastatic stage III or IV squamous cell carcinoma of the oropharynx. A GERCOR phase II ECHO‐07 study. Cancer medicine. pp. 721-731. [Online].